Clinical Trial Update: A Study of Zasocitinib in Adults With Nonsegmental Vitiligo [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Zasocitinib in adults with nonsegmental vitiligo, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Zasocitinib (Zasocitinib)

Snippet

Sponsor: Takeda | Conditions: Nonsegmental Vitiligo | Phase 2 | Status: RECRUITING